FindMyKOL
Clinical trialNCT00801697CompletedPhase 1Interventional

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment192HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the safety and preliminary immune response to recombinant adenoviral serotype 35 and 5 HIV-1 vaccines in HIV-uninfected adults.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Alabama Crs

    Birmingham, Alabama, United States

  • Bridge Hiv Crs

    San Francisco, California, United States

  • the Hope Clinic of the Emory Vaccine Center Crs

    Decatur, Georgia, United States

  • Brigham and Women'S Hospital Vaccine Crs (bwh Vcrs)

    Boston, Massachusetts, United States

  • Fenway Health (fh) Crs

    Boston, Massachusetts, United States

  • Columbia P&s Crs

    New York, New York, United States

  • New York Blood Center Crs

    New York, New York, United States

  • University of Rochester Vaccines To Prevent Hiv Infection Crs

    Rochester, New York, United States

  • Vanderbilt Vaccine (vv) Crs

    Nashville, Tennessee, United States

  • Seattle Vaccine and Prevention Crs

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

DNA VaccineDNA Vaccine placeboRAd35RAd35 placeboRAd5RAd5 placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2009
Primary completion
28 Feb 2011
Completion
30 Apr 2015
Last update posted
14 Oct 2021
Registered enrollment
192
Registry id
NCT00801697

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.